MENU
CDXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Codexis (CDXS) Earnings Date & Reports

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes... Show more

A.I. Advisor
published Earnings

CDXS is expected to report earnings to fall 3.56% to -15 cents per share on October 30

Codexis CDXS Stock Earnings Reports
Q3'25
Est.
$-0.15
Q2'25
Beat
by $0.03
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.09
Q3'24
Missed
by $0.05
The last earnings report on August 13 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 676.22K shares outstanding, the current market capitalization sits at 245.53M.
View a ticker or compare two or three
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CDXS showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of biocatalytic chemical processes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com